(1)
Zapanta, J. B. J.; Gorospe, C. V. Efficacy of a Single-Agent Ts1 (Tegafur, Gimeracil, and Oteracil) in Recurrent Gastric Cancer After Progression from Previous Oxaliplatin, Irinotecan, and Anti-Her2 Targeted Therapy: A Case Report. Asian Pac J Cancer Care 2025, 10, 989-992.